Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.31 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23728782 | 0.89 | HDAC1 (0.33) | HDAC1HDAC2HDAC8 | |
| SCHEMBL23728917 | 0.88 | P2RX3 (0.34) | — | |
| SCHEMBL23728897 | 0.84 | RPS6KA3 (0.33) | RPS6KA3P2RY12HDAC1HDAC2HDAC8 | |
| SCHEMBL23728958 | 0.84 | KDM4E (0.33) | RPS6KA3P2RY12 | |
| SCHEMBL23728934 | 0.84 | KDM4E (0.33) | RPS6KA3P2RY12 | |
| SCHEMBL23728940 | 0.79 | P2RY12 (0.31) | P2RY12 | |
| SCHEMBL23728778 | 0.77 | HRAS (0.39) | HDAC1HDAC2HDAC8 | |
| SCHEMBL23728754 | 0.76 | P2RX3 (0.42) | — | |
| Hydrochloric Acid SCHEMBL23728767 | 0.75 | P2RX3 (0.41) | — | |
| SCHEMBL23728829 | 0.75 | RPS6KA3 (0.39) | RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384506-A1 | PROCESS FOR POLYAMIDE SYNTHESIS | Design Therapeutics, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023014793-A1 | PROCESS FOR POLYAMIDE SYNTHESIS | Design Therapeutics, Inc. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-4100404-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| WO-2021158707-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. (US) | 2021-08-12 | — | — | WO | disclosed |